CLU and cancer: Clusterin (CLU) is a highly evolutionary conserved glycoprotein that controls crucial physiological processes and several cancer-associated events, including cancer cell proliferation, stemness, survival, metastasis, epithelial-mesenchymal transition (EMT), therapy resistance, and inhibition of programmed cell death, which in turn facilitates cancer growth and recurrence [55,56].